Michael Glen Bankson - Publications

Affiliations: 
2001 University of Texas Medical Branch, Galveston, TX 
Area:
pharmacology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Amato JL, Bankson MG, Yamamoto BK. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 946-54. PMID 16885935 DOI: 10.1038/Sj.Npp.1301174  0.705
2006 Breier JM, Bankson MG, Yamamoto BK. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 290-9. PMID 16399699 DOI: 10.1523/Jneurosci.3353-05.2006  0.673
2004 Bankson MG, Yamamoto BK. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. Journal of Neurochemistry. 91: 852-9. PMID 15525339 DOI: 10.1111/J.1471-4159.2004.02763.X  0.616
2002 Bankson MG, Cunningham KA. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 40-52. PMID 11751031 DOI: 10.1016/S0893-133X(01)00345-1  0.529
2001 Bankson MG, Cunningham KA. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. The Journal of Pharmacology and Experimental Therapeutics. 297: 846-52. PMID 11356903  0.563
1999 McCreary AC, Bankson MG, Cunningham KA. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors. The Journal of Pharmacology and Experimental Therapeutics. 290: 965-73. PMID 10454466  0.592
Show low-probability matches.